World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
15143
World Ranking
11828
National Ranking
215

Overview

Michael Huber is affiliated with the University of Zurich in Switzerland and has a body of research primarily focused in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly output includes 58 publications in Medicine and 31 in Biochemistry, Genetics and Molecular Biology, reflecting an interdisciplinary approach to biomedical sciences.

Their research extends to several subfields including Immunology, Molecular Biology, Public Health, Environmental and Occupational Health, Hematology, and Cell Biology. This range indicates a comprehensive engagement with both fundamental biological processes and applied medical sciences.

Huber's work encompasses a variety of key topics such as:

  • Mast cells and histamine
  • Chronic Myeloid Leukemia Treatments
  • Palliative Care and End-of-Life Issues
  • Monoclonal and Polyclonal Antibodies Research
  • Endoplasmic Reticulum Stress and Disease
  • Chronic Lymphocytic Leukemia Research
  • PI3K/AKT/mTOR signaling in cancer

Frequent collaborators include Thomas Wilhelm, Mirle Schemionek, Jörg B. Schulz, Sandro Capellmann, and Arno Reich, indicating active cooperation with researchers who contribute across multiple publications. This collaboration network supports interdisciplinary and translational research efforts.

Huber's publications have appeared in notable venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Journal of Pain and Symptom Management
  • Translational Stroke Research
  • European Journal of Immunology

Selected recent papers include:

  • "Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy" (2020, Nature Communications)
  • "Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke" (2020, Journal of Molecular Medicine)
  • "Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner" (2021, Translational Stroke Research)
  • "Increased Post-Hypoxic Oxidative Stress and Activation of the PERK Branch of the UPR in Trap1-Deficient Drosophila melanogaster Is Abrogated by Metformin" (2021, International Journal of Molecular Sciences)
  • "Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia" (2020, Leukemia)

Best Publications

  • Broad neutralization coverage of HIV by multiple highly potent antibodies

    Laura M. Walker;Michael Huber;Michael Huber;Katie J. Doores;Katie J. Doores;Emilia Falkowska;Emilia Falkowska

  • CD14 is required for MyD88-independent LPS signaling

    Zhengfan Jiang;Philippe Georgel;Xin Du;Louis Shamel

  • Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

    Alexandra Trkola;Herbert Kuster;Peter Rusert;Beda Joos

  • Progressive derangement of periinfarct viable tissue in ischemic stroke.

    W.-D. Heiss;M. Huber;G. R. Fink;K. Herholz

  • Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival.

    Janet Kalesnikoff;Michael Huber;Vivian Lam;Jacqueline E Damen

  • Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

    Ann J. Hessell;Eva G. Rakasz;David M. Tehrani;Michael Huber

  • IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

    Shafaqat Ali;Michael Huber;Christian Kollewe;Stephan C. Bischoff

  • The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation

    Michael Huber;Cheryl D. Helgason;Jacqueline E. Damen;Ling Liu

  • Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts.

    Nicolle Sitte;Michael Huber;Tilman Grune;Axel Ladhoff

  • Phosphatidylinositol (3,4,5)P3 Is Essential but Not Sufficient for Protein Kinase B (PKB) Activation; Phosphatidylinositol (3,4)P2 Is Required for PKB Phosphorylation at Ser-473: STUDIES USING CELLS FROM SH2-CONTAINING INOSITOL-5-PHOSPHATASE KNOCKOUT MICE *

    Michael P. Scheid;Michael Huber;Jacqueline E. Damen;Michael Hughes

  • Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors

    Susanna Minguet;Michael Huber;Lisa Rosenkranz;Wolfgang W. A. Schamel

  • R-form LPS, the master key to the activation of TLR4/MD-2-positive cells

    Michael Huber;Christoph Kalis;Simone Keck;Zhengfan Jiang

  • An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice

    Johannes Grosse;Attila Braun;David Varga-Szabo;Niklas Beyersdorf

  • Determinants of HIV-1 broadly neutralizing antibody induction

    Peter Rusert;Roger D Kouyos;Claus Kadelka;Hanna Ebner

  • Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.

    U R de Verdugo;H C Selinka;M Huber;B Kramer

  • SHIP Negatively Regulates IgE + Antigen-Induced IL-6 Production in Mast Cells by Inhibiting NF-κB Activity

    Janet Kalesnikoff;Nicole Baur;Michael Leitges;Michael R. Hughes

  • Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity

    Marina A. Freudenberg;Sandrine Tchaptchet;Simone Keck;György Fejer

  • Humoral immunity to HIV-1: neutralization and beyond.

    M. Huber;A. Trkola

  • Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.

    Idoia Busnadiego;Sonja Fernbach;Marie O. Pohl;Umut Karakus

  • Protein Kinase C-δ Is a Negative Regulator of Antigen-Induced Mast Cell Degranulation

    Michael Leitges;Kerstin Gimborn;Winfried Elis;Janet Kalesnikoff

Frequent Co-Authors

Alexandra Trkola
Alexandra Trkola University of Zurich
Jürg Böni
Jürg Böni University of Zurich
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Marina A. Freudenberg
Marina A. Freudenberg University of Freiburg
Michael Reth
Michael Reth University of Freiburg
Dietrich Keppler
Dietrich Keppler German Cancer Research Center
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Stefan Schmutz
Stefan Schmutz BOKU University
Gerald Krystal
Gerald Krystal BC Cancer Agency
Michael Leitges
Michael Leitges University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in biology and biochemistry often explore related career pathways in healthcare, research, and medical administration. For those looking to advance quickly, there are flexible online degrees and certification options that can open new doors in the medical field.

One route is pursuing an MBA in healthcare management. If you are cost-conscious, consider exploring the cheapest online mba healthcare programs, which offer leadership and business skills tailored to the medical sector.

Another prominent option is becoming a certified medical coder or biller. Understanding the differences between CPC and CCS certifications is crucial; the medical coding certification you choose can significantly impact your job responsibilities and earning potential.

Many biology graduates ask, how much do medical coders make? Salaries are competitive, especially for those with advanced certifications, and the profession offers steady employment opportunities.

For an in-depth look at future prospects, check out the medical coding job outlook. The demand for skilled professionals is expected to grow as the healthcare industry expands, making this a promising pathway for science and biochemistry majors seeking rewarding careers.

Best Scientists Citing Michael Huber

Trending Scientists

Recently Published Articles